Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia.
Iyo
Masaomi
M
Shirayama
Yukihiko
Y
Watanabe
Hiroyuki
H
Fujisaki
Mihisa
M
Miyatake
Ryosuke
R
Fukami
Goro
G
Shiina
Akihiro
A
Nakazato
Michiko
M
Shiraishi
Tetsuya
T
Ookami
Tsuyoshi
T
Hashimoto
Kenji
K
D000328:Adult; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D016666:Fluvoxamine / Q000627:therapeutic use*; D006801:Humans; D017480:Receptors, sigma / Q000819:agonists*; D012565:Schizophrenic Psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D000097605:Sigma-1 Receptor
D016666:Fluvoxamine; D017480:Receptors, sigma; D017367:Selective Serotonin Reuptake Inhibitors; D000097605:Sigma-1 Receptor